Of particular significance, SMARCD1 (encoding BAF60a) demonstrated marked overexpression in HCC specimens, mechanistically linked to mTOR pathway activation via upstream potentiation of PI3K/AKT signalling—a mechanism directly implicated in HCC [61]. Here, SMARCD1 is linked to hepatocellular carcinoma.